268 related articles for article (PubMed ID: 24023728)
1. Inhibitory effect of metformin and pyridoxamine in the formation of early, intermediate and advanced glycation end-products.
Ahmad S; Shahab U; Baig MH; Khan MS; Khan MS; Srivastava AK; Saeed M; Moinuddin
PLoS One; 2013; 8(9):e72128. PubMed ID: 24023728
[TBL] [Abstract][Full Text] [Related]
2. Quercetin as a finer substitute to aminoguanidine in the inhibition of glycation products.
Ashraf JM; Shahab U; Tabrez S; Lee EJ; Choi I; Ahmad S
Int J Biol Macromol; 2015; 77():188-92. PubMed ID: 25799884
[TBL] [Abstract][Full Text] [Related]
3. In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways.
Booth AA; Khalifah RG; Todd P; Hudson BG
J Biol Chem; 1997 Feb; 272(9):5430-7. PubMed ID: 9038143
[TBL] [Abstract][Full Text] [Related]
4. Study of pyridoxamine against glycation and reactive oxygen species production in human serum albumin as model protein: An in vitro & ex vivo approach.
Abdullah KM; Qais FA; Ahmad I; Hasan H; Naseem I
Int J Biol Macromol; 2018 Dec; 120(Pt B):1734-1743. PubMed ID: 30268752
[TBL] [Abstract][Full Text] [Related]
5. Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions.
Voziyan PA; Khalifah RG; Thibaudeau C; Yildiz A; Jacob J; Serianni AS; Hudson BG
J Biol Chem; 2003 Nov; 278(47):46616-24. PubMed ID: 12975371
[TBL] [Abstract][Full Text] [Related]
6. The pyridoxamine action on Amadori compounds: A reexamination of its scavenging capacity and chelating effect.
Adrover M; Vilanova B; Frau J; Muñoz F; Donoso J
Bioorg Med Chem; 2008 May; 16(10):5557-69. PubMed ID: 18434162
[TBL] [Abstract][Full Text] [Related]
7. A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation.
Voziyan PA; Metz TO; Baynes JW; Hudson BG
J Biol Chem; 2002 Feb; 277(5):3397-403. PubMed ID: 11729198
[TBL] [Abstract][Full Text] [Related]
8. Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage.
Voziyan PA; Hudson BG
Cell Mol Life Sci; 2005 Aug; 62(15):1671-81. PubMed ID: 15905958
[TBL] [Abstract][Full Text] [Related]
9. In vitro glycation of human serum albumin by dihydroxyacetone and dihydroxyacetone phosphate.
Seneviratne C; Dombi GW; Liu W; Dain JA
Biochem Biophys Res Commun; 2012 Jan; 417(2):817-23. PubMed ID: 22198436
[TBL] [Abstract][Full Text] [Related]
10. Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation.
Ruggiero-Lopez D; Lecomte M; Moinet G; Patereau G; Lagarde M; Wiernsperger N
Biochem Pharmacol; 1999 Dec; 58(11):1765-73. PubMed ID: 10571251
[TBL] [Abstract][Full Text] [Related]
11. Glycation of H1 Histone by 3-Deoxyglucosone: Effects on Protein Structure and Generation of Different Advanced Glycation End Products.
Ashraf JM; Rabbani G; Ahmad S; Hasan Q; Khan RH; Alam K; Choi I
PLoS One; 2015; 10(6):e0130630. PubMed ID: 26121680
[TBL] [Abstract][Full Text] [Related]
12. Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine.
Onorato JM; Jenkins AJ; Thorpe SR; Baynes JW
J Biol Chem; 2000 Jul; 275(28):21177-84. PubMed ID: 10801874
[TBL] [Abstract][Full Text] [Related]
13. Impact of wedelolactone in the anti-glycation and anti-diabetic activity in experimental diabetic animals.
Shahab U; Faisal M; Alatar AA; Ahmad S
IUBMB Life; 2018 Jun; 70(6):547-552. PubMed ID: 29624857
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Advanced Glycation End Products (AGEs) Accumulation by Pyridoxamine Modulates Glomerular and Mesangial Cell Estrogen Receptor α Expression in Aged Female Mice.
Pereira-Simon S; Rubio GA; Xia X; Cai W; Choi R; Striker GE; Elliot SJ
PLoS One; 2016; 11(7):e0159666. PubMed ID: 27428057
[TBL] [Abstract][Full Text] [Related]
15. How Does Pyridoxamine Inhibit the Formation of Advanced Glycation End Products? The Role of Its Primary Antioxidant Activity.
Ramis R; Ortega-Castro J; Caballero C; Casasnovas R; Cerrillo A; Vilanova B; Adrover M; Frau J
Antioxidants (Basel); 2019 Sep; 8(9):. PubMed ID: 31480509
[TBL] [Abstract][Full Text] [Related]
16. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.
Booth AA; Khalifah RG; Hudson BG
Biochem Biophys Res Commun; 1996 Mar; 220(1):113-9. PubMed ID: 8602828
[TBL] [Abstract][Full Text] [Related]
17. 2'-Deoxyribose Mediated Glycation Leads to Alterations in BSA Structure Via Generation of Carbonyl Species.
Rafi Z; Alouffi S; Khan MS; Ahmad S
Curr Protein Pept Sci; 2020; 21(9):924-935. PubMed ID: 32053073
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of quercetin in the formation of advance glycation end products of human serum albumin: An in vitro and molecular interaction study.
Alam MM; Ahmad I; Naseem I
Int J Biol Macromol; 2015 Aug; 79():336-43. PubMed ID: 25982953
[TBL] [Abstract][Full Text] [Related]
20. Metformin inhibition of glycation processes.
Beisswenger P; Ruggiero-Lopez D
Diabetes Metab; 2003 Sep; 29(4 Pt 2):6S95-103. PubMed ID: 14502106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
